ICD-9-CM 255.13 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 255.13 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Bartter's syndrome with hypercalciuria and nephrocalcinosis
Pseudoprimary aldosteronism (disorder)
Pseudoprimary hyperaldosteronism
Clinical Information
A group of disorders caused by defective salt reabsorption in the ascending loop of henle. It is characterized by severe salt-wasting, hypokalemia; hypercalciuria; metabolic alkalosis, and hyper-reninemic hyperaldosteronism without hypertension. There are several subtypes including ones due to mutations in the renal specific sodium-potassium-chloride symporters
A rare inherited syndrome characterized by juxtaglomerular cell hyperplasia, hyperaldosteronism, hypokalemia, and alkalosis. Patients have high levels of plasma renin concentration which is not associated with hypertension
Hypertrophy and hyperplasia of the juxtaglomerular apparatus with secondary hyperaldosteronism with normal blood pressure and hyperkalemic alkalosis in the absence of edema. Most patients show growth and mental retardation. Nephrocalcinosis and hypercalcinuria occur in some cases. Diuretic abuse may produce a syndrome with similar characteristics (pseudo-bartter or factitious bartter syndrome)
Transmitted as an autosomal recessive trait; characterized by hypertrophy and hyperplasia of the juxtaglomerular cells, and increased concentrations of renin, angiotensin ii, and aldosterone in the absence of edema and hypertension
2015 ICD-9-CM Diagnosis Code 255.13 
Bartter's (secondary hyperaldosteronism with juxtaglomerular hyperplasia) 255.13
hyperaldosteronism with hypokalemic alkalosis (Bartter's) 255.13
